Advaxis Depreciation & Amortization 2011-2026 | ADXS

Annual Depreciation & Amortization Advaxis

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
369 K	162 K	387 K	897 K	1.1 M	1.11 M	791 K	284 K	59 K	176 K	159 K	148 K	132 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.11 M	59 K	444 K

Quarterly Depreciation & Amortization Advaxis

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	44 K	18 K	-	-	30 K	192 K	-	50 K	124 K	229 K	683 K	200 K	200 K	285 K	848 K	300 K	300 K	265 K	827 K	300 K	300 K	158 K	554 K	200 K	180 K	46 K	164 K	68.5 K	49.1 K	6.9 K	28.4 K	14.2 K	7.25 K	41.9 K	20.7 K	44.8 K	42.7 K	38.7 K	118 K	40.1 K	39.1 K	35.4 K	110 K	37.4 K	37 K	32.3 K	99.3 K	34 K	32.3 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
848 K	6.9 K	162 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Amneal Pharmaceuticals AMRX	57.3 M	$ 12.32	-0.24 %	$ 3.86 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.36	-2.16 %	$ 362 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.57	-3.38 %	$ 16.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.67	-	$ 196 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.8	7.34 %	$ 256 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 319.52	-3.28 %	$ 41.9 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.86	-3.29 %	$ 4.69 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Cerus Corporation CERS	1.43 M	$ 1.84	-0.54 %	$ 351 M	USA
AbbVie ABBV	762 M	$ 206.37	-0.13 %	$ 365 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.13	0.98 %	$ 442 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.3	-2.65 %	$ 986 M	Canada